J. Robert Trenschel's Insider Trades & SAST Disclosures
J. Robert Trenschel's most recent trade in Palisade Bio Inc was a trade of 12,160 Common Stock Options done . Disclosure was reported to the exchange on Feb. 8, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Robert Trenschel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | Trenschel J. Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 12,160 | 12,160 | - | - | Common Stock Options | |
| Palisade Bio Inc | J. Robert Trenschel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 12,160 | 0 | - | - | Common Stock Options | |
| Palisade Bio Inc | J. Robert Trenschel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,880 | 6,880 | - | - | Common Stock Options | |
| Palisade Bio Inc | Trenschel J. Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,880 | 0 | - | - | Common Stock Options | |
| Palisade Bio Inc | J. Robert Trenschel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,820 | 10,920 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. Robert Trenschel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,820 | 0 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. Robert Trenschel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,100 | 0 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Trenschel J. Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 5,100 | 5,100 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 12,160 | 12,160 | - | - | Common Stock Options | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 5,100 | 5,100 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 31 Aug 2021 | 5,000 | 9,457 | - | 2.8 | 13,750 | Common Stock |
| Palisade Bio Inc | Robert J. Trenschel | Director | Purchase of securities on an exchange or from another person at price $ 2.89 per share. | 31 Aug 2021 | 3,400 | 12,857 | - | 2.9 | 9,826 | Common Stock |
| Palisade Bio Inc | Robert J. Trenschel | Director | Purchase of securities on an exchange or from another person at price $ 2.78 per share. | 31 Aug 2021 | 2,707 | 4,457 | - | 2.8 | 7,525 | Common Stock |
| Palisade Bio Inc | Robert J. Trenschel | Director | Purchase of securities on an exchange or from another person at price $ 2.98 per share. | 31 Aug 2021 | 2,142 | 14,999 | - | 3.0 | 6,383 | Common Stock |
| Palisade Bio Inc | Robert J. Trenschel | Director | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 31 Aug 2021 | 1,750 | 1,750 | - | 2.8 | 4,813 | Common Stock |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 304,479 | 304,479 | - | - | Common Stock | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 40,785 | 40,785 | - | - | Warrant (right to buy) | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 13,595 | 13,595 | - | - | Warrant (right to buy) | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 10,182 | 10,182 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 4,406 | 4,406 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 1,298 | 1,298 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Robert J. Trenschel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 1,223 | 1,223 | - | - | Warrant (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges